Thank you to our Prudential RideLondon 100 team who took on the challenge of cycling this great event from the Queen Elizabeth Olympic Park through the streets of London and into the countryside of Surrey returning to finish on the Mall.

Cancer52, an alliance of 90 organisations representing less common cancers, has published a briefing paper on the new Cancer Drugs Fund operating model. It provides an overview of the key features of the new model and the current Cancer52 position on the impact it may have on access to cancer drugs in England.

Earlier this month, our Chair, Susan Hay, and Trustee Keith Holmes wended their separate ways to deepest North Devon to accept a very generous donation from the Littleham Arts and Music Festival Charity Fundraising effort in 2015.

Thank you to all our online bidders and wonderful guests who helped us raise over £25,000 for Neuroblastoma UK. Alan Carr was a wonderful host and auctioneer and we are extremely grateful for his support.

In one of Coronation Street’s most heartbreaking storylines, Fiz Brown’s daughter Hope will be diagnosed with a highly aggressive cancer.

Cancer Research UK’s Drug Discovery Committee has awarded Newcastle University’s Northern Institute of Cancer Research £5mn to bring more cancer drugs to clinical trials

The eagle-eyed among you will have noticed that we have changed our name – but only slightly!  The Neuroblastoma Society has become Neuroblastoma UK.  Our principal purpose remains the same – to support and encourage UK-led research into the treatment of neuroblastoma, and to support families affected by neuroblastoma.  And we remain a fully volunteer led and driven organisation ensuring that around 95p from every £1 you donate will be channelled into finding new and better treatments, and one day a cure, for this aggressive childhood cancer.